Click on the links below to compare incidence to the number of active sites registered on clinicaltrials.gov for perspectives on patient competition. Comparison maps are also available by USA states, contact Pharm-Olam for more information.
ACTIVE SITES: Breast, Cervical, Colorectal, Head and Neck, Leukemia, Non-Hodgkin’s Lymphoma, Lung, Prostate
Pharm-Olam has extensive experience in emerging markets of Eastern Europe, India, South Africa, and Latin America which can offer many advantages over traditional clinical research markets including:
Lower costs for patient screening, hospitalization, and investigator fees
Fewer competing studies with patients that are more likely to enroll, more compliant, and less likely to drop out
Our offices and field-based staff are located in densely populated cities resulting in less travel time and fewer associated costs through the duration of the study
